{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["alendronate", "antiresorptive", "green tea", "osteoporosis", "raloxifene"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33732301", "DateRevised": {"Year": "2021", "Month": "03", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "05"}], "Language": ["eng"], "ELocationID": ["328", "10.3892/etm.2021.9759"], "Journal": {"ISSN": "1792-0981", "JournalIssue": {"Volume": "21", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Apr"}}, "Title": "Experimental and therapeutic medicine", "ISOAbbreviation": "Exp Ther Med"}, "ArticleTitle": "Green tea extract synergistically enhances the effectiveness of an antiresorptive drug on management of osteoporosis induced by ovariectomy in a rat model.", "Pagination": {"StartPage": "328", "MedlinePgn": "328"}, "Abstract": {"AbstractText": ["Antiresorptive drugs are effective for reducing bone loss in postmenopausal women, but their long-term application may be associated with adverse effects. The present study aimed to investigate the potential <i>in vivo</i> synergistic effects of green tea extract (GTE) and alendronate or raloxifene on the management of osteoporosis. Ovariectomized rats were fed orally with GTE, alendronate and raloxifene at different concentrations and various combinations for 4 weeks. Bone mineral density (BMD) at the lumbar spine, femur and tibia was monitored weekly using peripheral quantitative computed tomography. Bone microarchitecture in the left distal femur was analyzed using micro-CT, while serum biochemical levels were measured using ELISA kits at the end of the study. GTE alone effectively mitigated BMD loss and improved bone microarchitecture in rats. The co-administration of GTE and alendronate increased total BMD in the lumbar spine, femur and tibia. Particularly, GTE synergistically enhanced the effect of alendronate at a low dose on bone microarchitecture and decreased serum tartrate-resistant acid phosphatase. These findings imply that the dosage of certain antiresorptive agents could be reduced when they are administrated simultaneously with GTE, so that their adverse effects are minimized. The findings may be used to support the development of a new synergistic intervention between food therapy and pharmacotherapy on the management of osteoporosis in a long-term basis."], "CopyrightInformation": "Copyright: \u00a9 Siu et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}], "LastName": "Siu", "ForeName": "Wing Sum", "Initials": "WS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}], "LastName": "Ko", "ForeName": "Chun Hay", "Initials": "CH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}], "LastName": "Shiu", "ForeName": "Hoi Ting", "Initials": "HT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}], "LastName": "Li", "ForeName": "Kai Kai", "Initials": "KK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}], "LastName": "Shum", "ForeName": "Wai Ting", "Initials": "WT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}, {"Identifier": [], "Affiliation": "Department of Orthopaedics and Traumatology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}], "LastName": "Leung", "ForeName": "Ping Chung", "Initials": "PC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Orthopaedics and Traumatology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, SAR, P.R. China."}], "LastName": "Zhang", "ForeName": "Jin Fang", "Initials": "JF"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Exp Ther Med", "NlmUniqueID": "101531947", "ISSNLinking": "1792-0981"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Riggs BL, Melton LJ III. The worldwide problem of osteoporosis: Insights afforded by epidemiology. Bone. 1995;17 (17 Suppl):505S\u2013511S. doi: 10.1016/8756-3282(95)00258-4.", "ArticleIdList": ["10.1016/8756-3282(95)00258-4", "8573428"]}, {"Citation": "Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194 (2 Suppl):S3\u2013S11. doi: 10.1016/j.ajog.2005.08.047.", "ArticleIdList": ["10.1016/j.ajog.2005.08.047", "16448873"]}, {"Citation": "Varacallo MA, Fox EJ. Osteoporosis and its complications. Med Clin North Am. 2014;98:817\u2013831. doi: 10.1016/j.mcna.2014.03.007.", "ArticleIdList": ["10.1016/j.mcna.2014.03.007", "24994054"]}, {"Citation": "World Health Organization (WHO): WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level. Summary Meeting Report, Brussels, Belgium, 5-7 May 2004. WHO Press, Geneva, 2007."}, {"Citation": "Kling JM, Clarke BL, Sandhu NP. Osteoporosis prevention, screening, and treatment: A review. J Womens Health (Larchmt) 2014;23:563\u2013572. doi: 10.1089/jwh.2013.4611.", "ArticleIdList": ["10.1089/jwh.2013.4611", "PMC4089021", "24766381"]}, {"Citation": "Wells GA, Cranney A, Peterson J, Boucher M, Shea B, Robinson V, Coyle D, Tugwell P. Alendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women. Cochrane Database Syst Rev. 2008;23(CD001155) doi: 10.1002/14651858.CD001155.pub2.", "ArticleIdList": ["10.1002/14651858.CD001155.pub2", "18253985"]}, {"Citation": "Nelson HD, Haney EM, Dana T, Bougatsos C, Chou R. Screening for osteoporosis: An update for the U.S. Preventive services task force. Ann Intern Med. 2010;153:99\u2013111. doi: 10.7326/0003-4819-153-2-201007200-00262.", "ArticleIdList": ["10.7326/0003-4819-153-2-201007200-00262", "20621892"]}, {"Citation": "Pendrys DG, Silverman SL. Osteonecrosis of the jaws and bisphosphonates. Curr Osteoporos Rep. 2008;6:31\u201338. doi: 10.1007/s11914-008-0006-8.", "ArticleIdList": ["10.1007/s11914-008-0006-8", "18430398"]}, {"Citation": "Andreopoulou P, Bockman RS. Management of postmenopausal osteoporosis. Annu Rev Med. 2015;66:329\u2013342. doi: 10.1146/annurev-med-070313-022841.", "ArticleIdList": ["10.1146/annurev-med-070313-022841", "25386933"]}, {"Citation": "Ko CH, Siu WS, Lau CP, Lau CBS, Fung KP, Leung PC. Osteoprotective effects of fructus ligustri lucidi aqueous extract in aged ovariectomized rats. Chin Med. 2010;5(39) doi: 10.1186/1749-8546-5-39.", "ArticleIdList": ["10.1186/1749-8546-5-39", "PMC3003250", "21114821"]}, {"Citation": "Li G, Zhang XA, Zhang JF, Chan CY, Yew DTW, He ML, Lin MCM, Leung PC, Kung HF. Ethanol extract of fructus ligustri lucidi promotes osteogenesis of mesenchymal stem cells. Phyther Res. 2010;24:571\u2013576. doi: 10.1002/ptr.2987.", "ArticleIdList": ["10.1002/ptr.2987", "19813230"]}, {"Citation": "Zhang JF, Li G, Chan CY, Meng CL, Lin MCM, Chen YC, He ML, Leung PC, Kung HF. Flavonoids of herba epimedii regulate osteogenesis of human mesenchymal stem cells through BMP and Wnt/\u03b2-catenin signaling pathway. Mol Cell Endocrinol. 2010;314:70\u201374. doi: 10.1016/j.mce.2009.08.012.", "ArticleIdList": ["10.1016/j.mce.2009.08.012", "19703516"]}, {"Citation": "Hu J, Webster D, Cao J, Shao A. The safety of green tea and green tea extract consumption in adults-results of a systematic review. Regul Toxicol Pharmacol. 2018;95:412\u2013433. doi: 10.1016/j.yrtph.2018.03.019.", "ArticleIdList": ["10.1016/j.yrtph.2018.03.019", "29580974"]}, {"Citation": "Khan N, Mukhtar H. Tea and health: Studies in humans. Curr Pharm Des. 2013;19:6141\u20136147. doi: 10.2174/1381612811319340008.", "ArticleIdList": ["10.2174/1381612811319340008", "PMC4055352", "23448443"]}, {"Citation": "Hegarty VM, May HM, Khaw KT. Tea drinking and bone mineral density in older women. Am J Clin Nutr. 2000;71:1003\u20131007. doi: 10.1093/ajcn/71.4.1003.", "ArticleIdList": ["10.1093/ajcn/71.4.1003", "10731510"]}, {"Citation": "Ko CH, Lau KM, Choy WY, Leung PC. Effects of tea catechins, epigallocatechin, gallocatechin, and gallocatechin gallate, on bone metabolism. J Agric Food Chem. 2009;57:7293\u20137297. doi: 10.1021/jf901545u.", "ArticleIdList": ["10.1021/jf901545u", "19653629"]}, {"Citation": "Kashiwa K, Kotobuki N, Tadokoro M, Matsumura K, Hyon SH, Yoshiya S, Ohgushi H. Effects of epigallocatechin gallate on osteogenic capability of human mesenchymal stem cells after suspension in phosphate-buffered saline. Tissue Eng Part A. 2010;16:91\u2013100. doi: 10.1089/ten.TEA.2008.0636.", "ArticleIdList": ["10.1089/ten.TEA.2008.0636", "19640263"]}, {"Citation": "Ko CH, Siu WS, Wong HL, Shum WT, Fung KP, Lau CBS, Leung PC. Pro-bone and antifat effects of green tea and its polyphenol, epigallocatechin, in rat mesenchymal stem cells in vitro. J Agric Food Chem. 2011;59:9870\u20139876. doi: 10.1021/jf202015t.", "ArticleIdList": ["10.1021/jf202015t", "21877759"]}, {"Citation": "Shen CL, Wang P, Guerrieri J, Yeh JK, Wang JS. Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int. 2008;19:979\u2013990. doi: 10.1007/s00198-007-0527-5.", "ArticleIdList": ["10.1007/s00198-007-0527-5", "18084689"]}, {"Citation": "Shen CL, Yeh JK, Samathanam C, Cao JJ, Stoecker BJ, Dagda RY, Chyu MC, Wang JS. Protective actions of green tea polyphenols and alfacalcidol on bone microstructure in female rats with chronic inflammation. J Nutr Biochem. 2011;22:673\u2013680. doi: 10.1016/j.jnutbio.2010.05.007.", "ArticleIdList": ["10.1016/j.jnutbio.2010.05.007", "21036589"]}, {"Citation": "Shen CL, Smith BJ, Li J, Cao JJ, Song X, Newhardt MF, Corry KA, Tomison MD, Tang L, Wang JS, Chyu MC. Effect of long-term green tea polyphenol supplementation on bone architecture, turnover, and mechanical properties in middle-aged ovariectomized rats. Calcif Tissue Int. 2019;104:285\u2013300. doi: 10.1007/s00223-018-0489-y.", "ArticleIdList": ["10.1007/s00223-018-0489-y", "30413854"]}, {"Citation": "Dostal AM, Arikawa A, Espejo L, Kurzer MS. Long-term supplementation of green tea extract does not modify adiposity or bone mineral density in a randomized trial of overweight and obese postmenopausal women. J Nutr. 2016;146:256\u2013264. doi: 10.3945/jn.115.219238.", "ArticleIdList": ["10.3945/jn.115.219238", "PMC4725430", "26701796"]}, {"Citation": "Ko CH, Siu WS, Wong HL, Gao S, Shum WT, Lau CP, Cheng SW, Tam JCW, Hung LK, Fung KP, et al. In vivo study on the pharmacological interactions between a chinese herbal formula ELP and antiresorptive drugs to counteract osteoporosis. Evid Based Complement Altern Med. 2012;2012(203732) doi: 10.1155/2012/203732.", "ArticleIdList": ["10.1155/2012/203732", "PMC3488414", "23150739"]}, {"Citation": "Wu X, Xie CQ, Zhu QQ, Wang MY, Sun B, Huang YP, Shen C, An MF, Zhao YL, Wang XJ, Sheng J. Green tea (Camellia sinensis) aqueous extract alleviates postmenopausal osteoporosis in ovariectomized rats and prevents RANKL-induced osteoclastogenesis in vitro. Food Nutr Res. 2018;8(62) doi: 10.29219/fnr.v62.1478.", "ArticleIdList": ["10.29219/fnr.v62.1478", "PMC6190732", "30349445"]}, {"Citation": "Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331. doi: 10.4103/0976-0105.177703.", "ArticleIdList": ["10.4103/0976-0105.177703", "PMC4804402", "27057123"]}, {"Citation": "Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, V\u00e4\u00e4n\u00e4nen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab. 2006;52:499\u2013509.", "ArticleIdList": ["17078477"]}, {"Citation": "Rey JR, Cervino EV, Rentero ML, Crespo EC, Alvaro AO, Casillas M. Raloxifene: Mechanism of action, effects on bone tissue, and applicability in clinical traumatology practice. Open Orthop J. 2009;3:14\u201321. doi: 10.2174/1874325000903010014.", "ArticleIdList": ["10.2174/1874325000903010014", "PMC2687107", "19516920"]}, {"Citation": "Pavone V, Testa G, Giardina SMC, Vescio A, Restivo DA, Sessa G. Pharmacological therapy of osteoporosis: A systematic current review of literature. Front Pharmacol. 2017;8(830) doi: 10.3389/fphar.2017.00803.", "ArticleIdList": ["10.3389/fphar.2017.00803", "PMC5682013", "29163183"]}, {"Citation": "Dulloo AG, Seydoux J, Girardier L, Chantre P, Vandermander J. Green tea and thermogenesis: Interactions between catechin-polyphenols, caffeine and sympathetic activity. Int J Obes Relat Metab Disord. 2000;24:252\u2013258. doi: 10.1038/sj.ijo.0801101.", "ArticleIdList": ["10.1038/sj.ijo.0801101", "10702779"]}, {"Citation": "Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: A literature review. Chin Med. 2010;5(13) doi: 10.1186/1749-8546-5-13.", "ArticleIdList": ["10.1186/1749-8546-5-13", "PMC2855614", "20370896"]}, {"Citation": "Smith A. Effects of caffeine on human behavior. Food Chem Toxicol. 2002;40:1243\u20131255. doi: 10.1016/s0278-6915(02)00096-0.", "ArticleIdList": ["10.1016/s0278-6915(02)00096-0", "12204388"]}, {"Citation": "Cheng TO. Green tea may inhibit warfarin. Int J Cardiol. 2007;115(236) doi: 10.1016/j.ijcard.2006.04.003.", "ArticleIdList": ["10.1016/j.ijcard.2006.04.003", "16757048"]}, {"Citation": "Izzo AA. Interactions between herbs and conventional drugs: Overview of the clinical data. Med Princ Pract. 2012;21:404\u2013428. doi: 10.1159/000334488.", "ArticleIdList": ["10.1159/000334488", "22236736"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "8"}, {"Year": "2020", "Month": "9", "Day": "25"}, {"Year": "2021", "Month": "3", "Day": "18", "Hour": "6", "Minute": "48"}, {"Year": "2021", "Month": "3", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "19", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "2", "Day": "5"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33732301", "PMC7903424", "10.3892/etm.2021.9759", "ETM-0-0-09759"]}}], "PubmedBookArticle": []}